Momaja Life Sciences India Profile
Key Indicators
- Authorised Capital ₹ 50.00 K
- Paid Up Capital ₹ 50.00 K
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 154.47%
- Profit Growth 15413.38%
- Ebitda -29.07%
- Net Worth 1121.25%
- Total Assets 1345.41%
About Momaja Life Sciences India
Momaja Life Sciences India Private Limited (MLSIPL) is a Private Limited Foreign Company Incorporated In India incorporated in India on 07 September 2017 (Seven years and five months 6 days old ). Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 K and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Manishkumar Patel and Surekha Bhatt serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24303GJ2017FTC098997
-
Company No.
098997
-
Company Classification
Private Limited Foreign Company Incorporated In India
-
Incorporation Date
07 Sep 2017
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Momaja Life Sciences India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manishkumar Patel
|
Director | 03-Apr-2018 | Current |
|
Surekha Bhatt
|
Director | 19-Sep-2023 | Current |
Financial Performance of Momaja Life Sciences India.
Momaja Life Sciences India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 154.47% increase. The company also saw a substantial improvement in profitability, with a 15413.38% increase in profit. The company's net worth Soared by an impressive increase of 1121.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Momaja Life Sciences India?
Unlock access to Momaja Life Sciences India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Momaja Life Sciences India?
Momaja Life Sciences India has a workforce of 124 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Momaja Life Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Momaja Life Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
